Videos | Webinar: New Treatment for PV with Prof. Susanne Isfort and Silence Therapeutics

Published on September 29, 2025

Last August 28th, the Global MPN Scientific Foundation hosted a special webinar together with Silence Therapeutics, a biotech company developing precision RNA-based therapies for rare diseases such as Polycythemia Vera (PV).

This session brought together:

  • Prof. Susanne Isfort, hematologist, clinical researcher, and MPN expert from Germany.

  • Alberto Martinez, Senior Director of Clinical Science at Silence Therapeutics.

Together, they explored new ways to approach PV through clinical trials and innovative treatments.

 

Part 1: Silence Therapeutics and a Promising New Treatment for PV

In the first part, Alberto Martinez explained the science behind divesiran, a therapy currently in development for PV, and how Silence Therapeutics is advancing innovative approaches that could help reduce phlebotomies and improve quality of life. Full video:

https://vimeo.com/1119106892/336e8ba2ea?ts=0&share=copy 

In addition to Part 1, the webinar also includes:

Other news

Feeling exhausted with MPN? Take care of yourself today

September 24, 2025
A unique opportunity to improve how we live with MPNLiving with a Myeloproliferative Neoplasm (MPN) is not just about medical treatment. It’s also about finding ways to care for your energy, your body, your mind, and your daily wellbeing. That’s why we created the Wellbeing Project, a dedicated space for people with MPNs to explore practices that support quality of life from a holistic perspective

Peter’s Journey: Hope After a Stem Cell Transplant for Myelofibrosis

October 4, 2025
As part of our MPN Hope Series, we share the inspiring testimony of Peter Lercher, an Italian patient first diagnosed with polycythemia vera who later progressed to myelofibrosis. Four years ago, Peter received a life-changing stem cell transplant.He recalls the hardest moments: the chemotherapy that wiped out his bone marrow, weeks in isolation without defenses, pneumonia, and the loss of strengt